Eli Lilly and Co.

Page 25

BILLING CODE 4810-27-M FEDERAL TRADE COMMISSION 16 CFR Part 13 [Docket No. C-3021] Eli Lilly and Co.; Prohibited Trade Practices, and Affirmative Corrective Actions a g e n c y : Federal Trade Commission. a c t io n : Final order. SUMMARY: In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent order requires, among other things, an Indianapolis, Indiana manufacturer and seller of pharmaceuticals and other chemical substances, to cease engaging in several anticompetitive practices involving the United States finished insulin industry. Additionally the order requres Eli Lilly and Co. to grant certain licenses covering its existing and future insulin-related technology to existing and prospective competitors. DATES: Complaint and order issued April 29,1980.1 FOR FURTHER INFORMATION CONTACT: Paul W. Turley, Director, 3R, Chicago Regional Office, Federal Trade Commission, 55 East Monroe St., Suite 1437, Chicago, 111. 60603. (312) 353-4423. SUPPLEMENTARY INFORMATION: On Friday, Sept. 21,1979, there was published in the Federal Register, 44 FR 54726, a proposed consent agreement with analysis In the Matter of Eli Lilly and Company, a corporation, for the purpose of soliciting public comment. Interested parties were given sixty (60) days in which to submit comments, suggestions or objections regarding the proposed form of order. On Tuesday, December 18,1979, there was published in the Federal Register, 44 FR 74845, a notice extending the period of time for filing comments on the consent agreement for thirty days to January 17, 1980.

Comments were filed and considered by the Commission. The Commission 1 Copies of the Complaint and the Decision and Order filed with the original document

Page 26

44260 Federal Register / Vol. 45, No. 128 / Tuesday, July 1, 1980 / Rules and Regulations has ordered the issuance of the complaint in the form contemplated by the agreement, made its jurisdictional findings and entered its order to cease and desist, as set forth in the proposed consent agreement, in disposition of this proceeding.

The prohibited trade practices and/or corrective actions, as codified under 16 CFR Part 13, are as follows: Subpart- Combining or Conspiring: § 13.384 Combining or conspiring: § 13.388 To control allocations and solicitation of customers: § 13.395 To control marketing practices and conditions: § 13.435 To fix prices through patent license agreements; § 13.450 To limit distribution or dealing to regular, established or acceptable channels or classes: § 13.470 To restrain or monopolize trade. Subpart-Corrective Actions and/or Requirements: § 13.533 Corrective actions and/or requirements; § 13.533-43 Grant license(s). Subpart- Using Patents, Rights or Privileges Unlawfully: § 13.2485 Using patents, rights or privileges unlawfully. (Sec. 6, 38 Stat. 721; (15 U.S.C. 46). Interpret or apply sec. 5,. 38 Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended; (15 U.S.C. 45,18)) Carol M. Thomas, Secretary.

[FR Doc. 80-19710 Filed 6-30-80; 8:45 am]